drugset / Trial / NCT02666001

A Study to Assess the Drug-drug Interaction of BMS 663068 With Methadone and Also With Buprenorphine/Naloxone

NCT02666001

Phase 1 Completed 32 enrolled ViiV Healthcare GlaxoSmithKline · collab
Non-randomizedCrossoverOpen-labelOther

Summary

The study is being conducted to assess the effect of multiple doses of BMS-663068 on the exposure of methadone in subjects on a stable dose of methadone, and the exposure of buprenorphine and norbuprenorphine in subjects on a stable dose of buprenorphine and norbuprenorphine.

Timeline

Start
2016-01-12
Primary completion
2016-06-29
Completion
2016-06-29

Drugs

EvaluationDrugModalityDoseRoute
Subject Buprenorphine Other / unclassified
Subject Fostemsavir Other / unclassified 600 mg
Subject Methadone Other / unclassified
Subject Norbuprenorphine Small molecule